OCRELIZUMAB
UNII A10SJL62JY

Substance Identification & Data

This profile provides standardized clinical and technical data for Ocrelizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) A10SJL62JY.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 637334-45-3 and the RxNorm Concept ID (RxCUI) 1876366. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

A10SJL62JY

CAS Registry Number

637334-45-3

RxNorm Concept ID

1876366

Detailed Substance Profile

Preferred Name

OCRELIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

A10SJL62JY

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C66250

National Cancer Institute reference terminology for clinical and research data.

INN ID

8636

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

QQ-93

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ocrelizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

OCRELIZUMAB

OCRELIZUMAB-OCSQ

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL 2H7 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2H7 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL 2H7 .GAMMA.1-CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL 2H7 .KAPPA.-CHAIN, DIMER

OCRELIZUMAB [INN]

OCRELIZUMAB [JAN]

OCRELIZUMAB [MI]

OCRELIZUMAB [PURPLE BOOK CDER]

OCRELIZUMAB [USAN]

OCRELIZUMAB [WHO-DD]